Stem Cell Manufacturing System with Segmented Clean Rooms
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of induced pluripotent stem cells (iPS cells) for clinical applications faces challenges including high costs due to the need for clean rooms, variability in quality due to labor-intensive and skill-dependent processes, time-consuming establishment and evaluation, risk of contamination, and human resource limitations, which hinder efficient and timely large-scale production.
Innovation Solution
A stem cell manufacturing system comprising closed production devices, drive devices for maintaining a suitable environment, cryopreservation devices, and integrated information management systems to manage the production, transportation, and storage of somatic cells and iPS cells, including identification devices and conveyer systems for automation and quality control, and a cell transport apparatus for secure and timely transport of cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If clean rooms are used for iPS cell production, then contamination is prevented, but production costs increase significantly
Solution Approach 1:
The system divides the production environment into multiple isolated clean room modules (first clean room for somatic cell collection, second clean room for iPS cell production, third clean room for cryopreservation). Each module maintains independent contamination control, allowing production to proceed in controlled segments rather than requiring a single large expensive clean room facility.
Solution Approach 2:
A conveyer system acts as an intermediary mechanism to transport cells and materials between clean room modules through sealed passages. This automated conveyance system maintains contamination barriers while enabling material transfer, replacing manual handling that would compromise clean room integrity.
2Ease of operation
If manual processes are used for cell production, then flexibility is maintained, but quality consistency deteriorates
Solution Approach 1:
The system incorporates automated information management that self-monitors and records critical parameters (temperature, timing, operational status) throughout the cell production process. The system automatically tracks somatic cell collection data, production parameters, and cryopreservation conditions, eliminating reliance on manual recording and reducing human error while maintaining operational flexibility.
Solution Approach 2:
The information management system provides continuous feedback by monitoring and recording production parameters, allowing operators to adjust processes while maintaining quality standards. The system tracks temperature variations, timing sequences, and operational status, providing real-time data that enables quality control without rigid automation.
3Reliability
If sequential production for each individual is used, then contamination risk is minimized, but production time increases
Solution Approach 1:
The production system is segmented into multiple independent clean room modules that can operate in parallel. The first clean room collects somatic cells, the second produces iPS cells, and the third performs cryopreservation. These segmented modules enable simultaneous processing of multiple individuals while each maintains its own contamination barriers.
Solution Approach 2:
The system enables continuous production workflows where somatic cell collection, iPS cell production, and cryopreservation can proceed concurrently in different modules. The automated conveyer system ensures continuous material transfer between modules without interrupting production flows, maintaining continuous useful action across the entire manufacturing process.
4Manufacturing precision
If integrated information management is implemented, then quality control improves, but system complexity increases
Solution Approach 1:
The information management system serves multiple functions: it records somatic cell collection data, monitors production parameters, tracks cryopreservation conditions, and provides quality control feedback. This universal system handles diverse information types through a single integrated platform, managing complexity through functional consolidation rather than proliferation of separate systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables efficient, cost-effective, and timely production of high-quality iPS cells on a large scale while preventing contamination, reducing human errors, and ensuring sophisticated quality management, thereby addressing the limitations of existing methods.
Implementation Method 1
one or more cryopreservation devices configured to cryopreserve the produced stem cells
Data Source
AI summary
A stem cell manufacturing system for manufacturing stem cells from somatic cells includes: one or more closed production device(s) configured to produce stem cells from somatic cells; one or more drive device(s) configured to be connected with the production device(s) and drive the production device(s) in such a manner as to maintain the production device(s) in an environment suitable for producing stem cells; one or more cryopreservation device(s) configured to cryopreserve the produced stem cells; a first memory device configured to store whether or not somatic cells have been introduced to the production device(s), as a first state; a second memory device configured to store whether or not the production device(s) is/are connected with the drive device(s), as a second state; and a third memory device configured to store whether or not the produced stem cells can be placed in the cryopreservation device(s), as a third state.